Category: News

gehonoreerde projecten
Funded Projects in the Human Capital Growth 2024 Funding Round
October 30, 2025

Good news: six new projects have been awarded funding within the PharmaNL Human Capital Growth (HCG) program line. These projects specifically focus on developing flexible post-secondary, post-bachelor, and post-graduate education tailored to the evolving needs of the pharmaceutical sector. The PharmaNL Human Capital Growth 2024 call marks the second funding round within the HCG program […]

impact-series-5
Impact Series Episode 5: Groningen Human Capital for Life Sciences. Training program gives professionals an edge in bioanalysis and gene technology
September 4, 2025

In the PharmaNL Impact Series, we show how innovative projects come to life thanks to PharmaNL funding: what first results have been achieved, what challenges arise, and what lessons they offer to others. In this fifth episode, the spotlight is on the Groningen Human Capital for Life Sciences project, led by the LIFE Cooperative together […]

impact-series-4-adinda-diekstra
Impact Series 4: Early Drug Discovery Education Track. Future-proof training for pharma professionals
July 7, 2025

“The pharmaceutical industry is evolving at lightning speed. If we don’t continuously upskill our professionals, they’ll fall behind, and that will negatively impact the entire sector.” With this clear message, Adinda Diekstra, Programme Manager for Post-Bachelor Courses & Training at HAN University of Applied Sciences, underscores the importance of the Early Drug Discovery Education Track […]

Impact Series 3: Nanoworx. Smart Optimization for Scale-Up Makes the Difference
June 25, 2025

In the PharmaNL Impact Series, we spotlight innovative projects that have taken off thanks to funding from PharmaNL. What are the initial results? What challenges have emerged? And what can others learn from these experiences? In this third episode, we take a closer look at Nanoworx, a promising initiative within the PharmaNL program line Shared […]

iPsomics
Impact Series 2: iPsomics. From Academic Innovation to Personalized Cancer Treatment
June 19, 2025

The PharmaNL Impact Series showcases real-life examples of how PharmaNL projects are progressing. What early results are emerging, what challenges are being faced, and what lessons can others take from them? In this second episode, we caught up with Peter Ketelaar and Floris Foijer of iPsomics, a promising life science start-up born out of the […]

English Translation of Investment Agenda Part 3 Now Available
June 12, 2025

The English translation of PharmaNL Investment Agenda Part 3 is now available. This document, part of the agenda presented on 22 August 2024, focuses on the Shared Development Infrastructure programme line. The Investment Agenda serves as a roadmap for targeted investments aimed at strengthening the Dutch pharmaceutical value chain.

Impact Series 1: Future-oriented education for biomedical and pharmaceutical professionals
June 10, 2025

PharmaNL Impact Series – Updates on ongoing projects and their impact In the PharmaNL Impact Series, we provide insights into projects that have recently commenced under PharmaNL’s two program lines: Human Capital Growth and Shared Development Infrastructure. Each article focuses on one project: its objectives, progress made so far, challenges faced by the teams, and […]

terugblik
From Pitch to Partnership: PharmaNL Connection Days 2025
April 16, 2025

Three rooms filled with engaged professionals, exchange, and ideas shaping the future of the pharmaceutical sector—that was the outcome of the PharmaNL Connection Days in March and April 2025. The central theme was to stimulate project applications for the Shared Development Infrastructure (SDI) subsidy call, which opened on March 18. Floor van de Watering, program […]

Insight as a Foundation: PharmaNL’s 4DMap and Gap Analysis
April 10, 2025

PharmaNL has set itself an ambitious goal: strengthening and future-proofing the pharmaceutical sector by optimizing both the infrastructure for drug development and the training opportunities. PharmaNL is doing this within two main program lines: Shared Development Infrastructure and Human Capital Growth. To accurately map out where the greatest needs and bottlenecks lie, PharmaNL conducts a […]

Meet PharmaNL: ZonMw as an Indispensable Collaboration Partner in Innovation and Funding
March 31, 2025

Following the first Meet PharmaNL series, in which we introduced the PharmaNL board, we now turn our focus to our collaboration partners. These partners play a crucial role in achieving PharmaNL’s objectives. In this edition, ZonMw takes center stage. With its expertise in grant procedures and knowledge dissemination, ZonMw contributes to the selection and funding […]